Browse Infectious Disease General Articles by Topic

Smallpox and Monkeypox Vaccine, Live, Non-Replicating (Jynneos)

Jynneos can be administered to prevent smallpox and monkeypox in adults age 18 years and older who are at high risk for contracting the infections.

Cirrhosis and Infections

Infections in patients with cirrhosis are frequent and potentially lethal, with pneumonia associated with the highest risk for mortality.

Headache is a common feature of acute COVID-19 infection, as well as a long-standing feature of “long COVID” after recovery from the acute infection. Treatment is symptomatic, based on the characteristics of the headache syndrome.

FDA Authorizes Updated Boosters to Protect Against Omicron

Agency prepares for potential cold weather COVID-19 case spike with latest vaccine solution.

Is It Possible to Sway Hesitant Patients to Take the COVID-19 Vaccine?

A survey conducted in a small New York county reveals some challenges moving forward.

COVID-19 Infection More Likely to Inflame Heart Than Vaccine

Researchers noted patients were much more likely to be afflicted with myocarditis after a SARS-CoV-2 infection than after receiving a vaccine.

U.S. N95 Respirator Supply Finally Deemed Adequate

Federal regulators remove devices from shortage list.

Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373)

Novavax is authorized to be administered to patients age 18 years and older for active immunization to prevent COVID-19 caused by SARS-CoV-2.

COVID-19 Rebound

Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with Paxlovid occurs in a tiny percentage of patients and generally is mild and self-limited.

COVID-19: Duration of Shedding of Transmissible Virus

Patients with COVID-19 were found, by culture, to shed replication-competent virus after an initial PCR test for median durations of four to five days.